Turtle Beach [TBCH] vs Zepp Health [ZEPP] Detailed Stock Comparison
Turtle Beach
NASDAQ
Loading...
Zepp Health
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Turtle Beach wins in 9 metrics, Zepp Health wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Turtle Beach | Zepp Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 18.92 | -2.80 | Zepp Health |
| Price-to-Book Ratio | 2.30 | 0.81 | Zepp Health |
| Debt-to-Equity Ratio | 49.80 | 46.23 | Zepp Health |
| PEG Ratio | -0.11 | -1,300.00 | Zepp Health |
| EV/EBITDA | 6.76 | -66.54 | Zepp Health |
| Profit Margin (TTM) | 4.03% | -44.54% | Turtle Beach |
| Operating Margin (TTM) | -2.03% | -47.68% | Turtle Beach |
| Return on Equity | 12.49% | -28.56% | Turtle Beach |
| Return on Assets (TTM) | 8.87% | -5.65% | Turtle Beach |
| Free Cash Flow (TTM) | $847,000 | $-25.88M | Turtle Beach |
| 1-Year Return | 6.87% | 507.48% | Zepp Health |
| Price-to-Sales Ratio (TTM) | 0.74 | 1.03 | Turtle Beach |
| Enterprise Value | $330.57M | $3.02B | Zepp Health |
| EV/Revenue Ratio | 0.87 | 16.66 | Turtle Beach |
| Gross Profit Margin (TTM) | 36.57% | 37.27% | Zepp Health |
| Revenue per Share (TTM) | $19 | $11 | Turtle Beach |
| Earnings per Share (Diluted) | $0.74 | $-4.96 | Turtle Beach |
| Beta (Stock Volatility) | 2.01 | 0.85 | Zepp Health |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Turtle Beach vs Zepp Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Turtle Beach | -3.71% | -3.71% | -2.78% | 23.89% | -16.77% | -17.89% |
| Zepp Health | -3.42% | 16.80% | 360.99% | 381.48% | 357.75% | 352.96% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Turtle Beach | 6.87% | -0.85% | -23.79% | 62.79% | 100.00% | 100.00% |
| Zepp Health | 507.48% | 92.31% | -71.37% | -71.44% | -71.44% | -71.44% |
Performance & Financial Health Analysis: Turtle Beach vs Zepp Health
| Metric | TBCH | ZEPP |
|---|---|---|
| Market Information | ||
| Market Cap | $282.05M | $186.79M |
| Market Cap Category | Small cap | Micro cap |
| 10 Day Avg. Volume | 186,020 | 297,500 |
| 90 Day Avg. Volume | 225,503 | 1,000,603 |
| Last Close | $14.00 | $13.00 |
| 52 Week Range | $8.78 - $19.50 | $2.06 - $15.85 |
| % from 52W High | -28.21% | -17.98% |
| All-Time High | $89.55 (May 13, 2013) | $81.00 (Feb 15, 2021) |
| % from All-Time High | -84.37% | -83.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | -0.03% |
| Quarterly Earnings Growth | 0.14% | 5.89% |
| Financial Health | ||
| Profit Margin (TTM) | 0.04% | -0.45% |
| Operating Margin (TTM) | -0.02% | -0.48% |
| Return on Equity (TTM) | 0.12% | -0.29% |
| Debt to Equity (MRQ) | 49.80 | 46.23 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.09 | $16.15 |
| Cash per Share (MRQ) | $0.58 | $0.34 |
| Operating Cash Flow (TTM) | $18.96M | $-25,970,000 |
| Levered Free Cash Flow (TTM) | $15.02M | $-137,800,733 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Turtle Beach vs Zepp Health
| Metric | TBCH | ZEPP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 18.92 | -2.80 |
| Forward P/E | 10.38 | -1,300.00 |
| PEG Ratio | -0.11 | -1,300.00 |
| Price to Sales (TTM) | 0.74 | 1.03 |
| Price to Book (MRQ) | 2.30 | 0.81 |
| Market Capitalization | ||
| Market Capitalization | $282.05M | $186.79M |
| Enterprise Value | $330.57M | $3.02B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.87 | 16.66 |
| Enterprise to EBITDA | 6.76 | -66.54 |
| Risk & Other Metrics | ||
| Beta | 2.01 | 0.85 |
| Book Value per Share (MRQ) | $6.09 | $16.15 |
Financial Statements Comparison: Turtle Beach vs Zepp Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | TBCH | ZEPP |
|---|---|---|
| Revenue/Sales | $63.90M | $38.54M |
| Cost of Goods Sold | $40.53M | $24.18M |
| Gross Profit | $23.37M | $14.36M |
| Research & Development | $3.99M | $12.38M |
| Operating Income (EBIT) | $-1.30M | $-18.38M |
| EBITDA | $1.53M | $-17.79M |
| Pre-Tax Income | $-773,000 | $-19.27M |
| Income Tax | $-109,000 | $110,000 |
| Net Income (Profit) | $-664,000 | $-19.74M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | TBCH | ZEPP |
|---|---|---|
| Cash & Equivalents | $11.68M | $76.43M |
| Total Current Assets | $142.24M | $242.46M |
| Total Current Liabilities | $72.43M | $212.34M |
| Long-Term Debt | $45.54M | $71.16M |
| Total Shareholders Equity | $120.87M | $232.04M |
| Retained Earnings | $-118.76M | $8.88M |
| Property, Plant & Equipment | $17.26M | $9.56M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | TBCH | ZEPP |
|---|---|---|
| Operating Cash Flow | $42.97M | $-14.63M |
| Capital Expenditures | $-166,000 | $-2.92M |
| Free Cash Flow | $40.29M | $-16.89M |
| Debt Repayment | $-108.41M | N/A |
| Common Stock Repurchase | $-1.75M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TBCH | ZEPP |
|---|---|---|
| Shares Short | 2.77M | 308,546 |
| Short Ratio | 10.71 | 0.25 |
| Short % of Float | 0.17% | 0.05% |
| Average Daily Volume (10 Day) | 186,020 | 297,500 |
| Average Daily Volume (90 Day) | 225,503 | 1,000,603 |
| Shares Outstanding | 19.96M | 231.98M |
| Float Shares | 11.13M | 98.58M |
| % Held by Insiders | 0.29% | 0.06% |
| % Held by Institutions | 0.60% | 0.26% |
Dividend Analysis & Yield Comparison: Turtle Beach vs Zepp Health
| Metric | TBCH | ZEPP |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |